|
DIXDC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.041400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93096999999698E-05 |
| Normal-vs-Stage2 |
4.838200E-01 |
| Normal-vs-Stage3 |
2.652200E-01 |
| Normal-vs-Stage4 |
1.989760E-01 |
| Stage1-vs-Stage2 |
6.835800E-02 |
| Stage1-vs-Stage3 |
2.333600E-02 |
| Stage1-vs-Stage4 |
1.117020E-01 |
| Stage2-vs-Stage3 |
9.105000E-01 |
| Stage2-vs-Stage4 |
7.176800E-01 |
| Stage3-vs-Stage4 |
7.504800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.973600E-04 |
| Normal-vs-AfricanAmerican |
8.576000E-01 |
| Normal-vs-Asian |
1.168440E-01 |
| Caucasian-vs-AfricanAmerican |
3.586400E-02 |
| Caucasian-vs-Asian |
3.436400E-01 |
| AfricanAmerican-vs-Asian |
5.502400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.917400E-03 |
| Normal-vs-Female |
2.603900E-03 |
| Male-vs-Female |
4.426000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.810000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.942700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.940000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.856580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.728850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.637020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.073000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.490200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.455000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.637400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.842410E-02 |
| Normal-vs-Grade 2 |
1.69347999999792E-05 |
| Normal-vs-Grade 3 |
1.518480E-02 |
| Normal-vs-Grade 4 |
5.235200E-01 |
| Grade 1-vs-Grade 2 |
3.778400E-01 |
| Grade 1-vs-Grade 3 |
1.073170E-01 |
| Grade 1-vs-Grade 4 |
1.527690E-02 |
| Grade 2-vs-Grade 3 |
6.109600E-02 |
| Grade 2-vs-Grade 4 |
4.618400E-04 |
| Grade 3-vs-Grade 4 |
2.255900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.01594338181621E-12 |
| Normal-vs-ccB subtype |
2.557600E-01 |
| ccA subtype-vs-ccB subtype |
1.94289029309402E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.356900E-03 |
| Normal-vs-N1 |
3.873600E-01 |
| N0-vs-N1 |
9.929600E-02 |
|
|
